Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes.
Farina A, Villagrán-García M, Vogrig A, Zekeridou A, Muñiz-Castrillo S, Velasco R, Guidon AC, Joubert B, Honnorat J.
Lancet Neurol. 2024 Jan;23(1):81-94. doi: 10.1016/S1474-4422(23)00369-1.
Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment.
Nissen MS, Ryding M, Meyer M, Blaabjerg M.
CNS Neurol Disord Drug Targets. 2020;19(8):584-598. doi: 10.2174/1871527319666200708133103.
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.
Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer MJ; Autoimmune Encephalitis Alliance Clinicians Network.
J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):757-768. doi: 10.1136/jnnp-2020-325300. Epub 2021 Mar 1.
Diagnostic Approach and Treatment Regimens in Adult Patients Suffering from Antibody- mediated or Paraneoplastic Encephalitis.
Macher S, Bsteh G, Berger T, Höftberger R.
Curr Pharm Des. 2022;28(6):454-467. doi: 10.2174/1381612828666220131093259.
Autoimmune neuromyotonia.
Comperat L, Pegat A, Honnorat J, Joubert B.
Curr Opin Neurol. 2022 Oct 1;35(5):597-603. doi: 10.1097/WCO.0000000000001104. Epub 2022 Aug 19.
Paraneoplastic neurological syndromes: a practical approach to diagnosis and management.
Binks S, Uy C, Honnorat J, Irani SR.
Pract Neurol. 2022 Feb;22(1):19-31. doi: 10.1136/practneurol-2021-003073. Epub 2021 Sep 11.
Autoimmune central nervous system disorders: Antibody testing and its clinical utility.
Gilligan M, McGuigan C, McKeon A.
Clin Biochem. 2024 Apr;126:110746. doi: 10.1016/j.clinbiochem.2024.110746. Epub 2024 Mar 8.
Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations.
Kunchok A, McKeon A, Zekeridou A, Flanagan EP, Dubey D, Lennon VA, Klein CJ, Mills JR, Pittock SJ.
Mayo Clin Proc. 2022 Mar;97(3):547-559. doi: 10.1016/j.mayocp.2021.07.023. Epub 2021 Dec 23.
Paraneoplastic/autoimmune myelopathies.
Montalvo M, Flanagan EP.
Handb Clin Neurol. 2024;200:193-201. doi: 10.1016/B978-0-12-823912-4.00017-7.
Which antibody and which cancer in which paraneoplastic syndromes?
Gozzard P, Maddison P.
Pract Neurol. 2010 Oct;10(5):260-70. doi: 10.1136/jnnp.2010.224105.
